0001235802-19-000063.txt : 20190626
0001235802-19-000063.hdr.sgml : 20190626
20190626163638
ACCESSION NUMBER: 0001235802-19-000063
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190624
FILED AS OF DATE: 20190626
DATE AS OF CHANGE: 20190626
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Parsons James T.
CENTRAL INDEX KEY: 0001759855
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36291
FILM NUMBER: 19922090
MAIL ADDRESS:
STREET 1: 2 CARLSON PARKWAY
STREET 2: SUITE 260
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55447
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DiaMedica Therapeutics Inc.
CENTRAL INDEX KEY: 0001401040
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: Z4
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 CARLSON PARKWAY
STREET 2: SUITE 260
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55447
BUSINESS PHONE: (763) 496-5454
MAIL ADDRESS:
STREET 1: 2 CARLSON PARKWAY
STREET 2: SUITE 260
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55447
FORMER COMPANY:
FORMER CONFORMED NAME: DiaMedica Inc.
DATE OF NAME CHANGE: 20070525
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2019-06-24
0
0001401040
DiaMedica Therapeutics Inc.
DMAC
0001759855
Parsons James T.
2 CARLSON PARKWAY
SUITE 260
MINNEAPOLIS
MN
55447
1
0
0
0
Voting Common Shares, no par value per share
6100
D
Stock Option (right to buy)
4.6
2019-06-24
4
A
0
12950
0
A
2029-06-23
Common Shares
12950
12950
D
Includes 3,850 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan.
Vests in four nearly equal quarterly installments over one year.
/s/ Amy Culbert, attorney-in-fact
2019-06-26